Djaya Kools

Djaya Kools

Auto-generated profile, based on publicly available information

Djaya Kools

Department of Neurosurgery, Onze-Lieve-Vrouw Hospital Aalst, Aalst, Belgium

Research Focus & Metrics

Academic Career Length

18Years (2009-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
6 March 2019 in Journal of Bone and Joint Surgery
Verified
Journal Article
Open access
JDJulius Dengler
Julius Dengler
DKDjaya Kools
Djaya Kools
RPRobert Pflugmacher
Robert Pflugmacher
Alessandro GasbarriniAlessandro Gasbarrini
Alessandro Gasbarrini
DPDomenico Prestamburgo
Domenico Prestamburgo
BSBengt Sturesson
Bengt Sturesson
Background: Sacroiliac joint pain is increasingly recognized as a cause of low back pain. We compared the safety and effectiveness of minimally invasive sacroiliac joint arthrodesis using triangular titanium implants and conservative management in patients with chronic sacroiliac joint pain. Methods: This study was a prospective, multicenter randomized controlled trial of adults with chronic sacroiliac joint pain assigned to either conservative management or sacroiliac joint arthrodesis with triangular titanium implants. The study end points included self-rated low back pain (visual analog scale [VAS]), back dysfunction (Oswestry Disability Index [ODI]), and quality of life. Ninety percent of subjects in both groups completed the study. Results: Between June 6, 2013, and May 15, 2015, 103 subjects were randomly assigned to conservative management (n = 51) or sacroiliac joint arthrodesis (n = 52). At 2 years, the mean low back pain improved by 45 points (95% confidence interval [CI], 37 to 54 points) after sacroiliac joint arthrodesis and 11 points (95% CI, 2 to 20 points) after conservative management, with a mean difference between groups of 34 points (p < 0.0001). The mean ODI improved by 26 points (95% CI, 21 to 32 points) after sacroiliac joint arthrodesis and 8 points (95% CI, 2 to 14 points) after conservative management, with a mean difference between groups of 18 points (p < 0.0001). Parallel improvements were seen in quality of life. In the sacroiliac joint arthrodesis group, the prevalence of opioid use decreased from 56% at baseline to 33% at 2 years (p = 0.009), and no significant change was observed in the conservative management group (47.1% at baseline and 45.7% at 2 years). Subjects in the conservative management group, after crossover to the surgical procedure, showed improvements in all measures similar to those originally assigned to sacroiliac joint arthrodesis. In the first 6 months, the frequency of adverse events did not differ between groups (p = 0.664). By month 24, we observed 39 severe adverse events after sacroiliac joint arthrodesis, including 2 cases of sacroiliac joint pain, 1 case of a postoperative gluteal hematoma, and 1 case of postoperative nerve impingement. The analysis of computed tomographic (CT) imaging at 12 months after sacroiliac joint arthrodesis showed radiolucencies adjacent to 8 implants (4.0% of all implants). Conclusions: For patients with chronic sacroiliac joint pain due to joint degeneration or disruption, minimally invasive sacroiliac joint arthrodesis with triangular titanium implants was safe and more effective throughout 2 years in improving pain, disability, and quality of life compared with conservative management. Level of Evidence: Therapeutic Level I. See Instructions for Authors for a complete description of levels of evidence.

14 May 2016 in European Spine Journal
Verified
Journal Article
Open access
PDF file
BSBengt Sturesson
Bengt Sturesson
DKDjaya Kools
Djaya Kools
RPRobert Pflugmacher
Robert Pflugmacher
Alessandro GasbarriniAlessandro Gasbarrini
Alessandro Gasbarrini
DPDomenico Prestamburgo
Domenico Prestamburgo
JDJulius Dengler
Julius Dengler
Purpose To compare the safety and effectiveness of minimally invasive sacroiliac joint fusion (SIJF) using triangular titanium implants vs conservative management (CM) in patients with chronic sacroiliac joint (SIJ) pain. Methods 103 adults with chronic SIJ pain at nine sites in four European countries were randomly assigned to and underwent either minimally invasive SIJF using triangular titanium implants (N = 52) or CM (N = 51). CM was performed according to the European guidelines for the diagnosis and management of pelvic girdle pain and consisted of optimization of medical therapy, individualized physical therapy (PT) and adequate information and reassurance as part of a multifactorial treatment. The primary outcome was the difference in change in self-rated low back pain (LBP) at 6 months. Additional endpoints included quality of life using EQ-5D-3L, disability using Oswestry Disability Index (ODI), SIJ function using active straight leg raise (ASLR) test and adverse events. NCT01741025. Results At 6 months, mean LBP improved by 43.3 points in the SIJF group and 5.7 points in the CM group (difference of 38.1 points, p < 0.0001). Mean ODI improved by 26 points in the SIJF group and 6 points in the CM group (p < 0.0001). ASLR, EQ-5D-3L, walking distance and satisfaction were statistically superior in the SIJF group. The frequency of adverse events did not differ between groups. One case of postoperative nerve impingement occurred in the surgical group. Conclusions In patients with chronic SIJ pain, minimally invasive SIJF using triangular titanium implants was safe and more effective than CM in relieving pain, reducing disability, improving patient function and quality of life.

1 September 2017
Verified
Journal Article
Closed access
JDJulius Dengler
Julius Dengler
DKDjaya Kools
Djaya Kools
RPRobert Pflugmacher
Robert Pflugmacher
Alessandro GasbarriniAlessandro Gasbarrini
Alessandro Gasbarrini
DPDomenico Prestamburgo
Domenico Prestamburgo
BSBengt Sturesson
Bengt Sturesson

15 September 2016 in Acta Neurochirurgica
Verified
Journal Article
Closed access
PDF file
TGthe iMIA study group
the iMIA study group
JDJulius Dengler
Julius Dengler
BSBengt Sturesson
Bengt Sturesson
DKDjaya Kools
Djaya Kools
DPDomenico Prestamburgo
Domenico Prestamburgo
Peter VajkoczyPeter Vajkoczy
Peter Vajkoczy

29 June 2010 in Skeletal Radiology
Verified
Journal Article
Closed access
PDF file
FVFilip M. Vanhoenacker
Filip M. Vanhoenacker
GPGunther De Praeter
Gunther De Praeter
DKDjaya Kools
Djaya Kools
MVMaurits Voormolen
Maurits Voormolen
PPPaul Maria R. Parizel
Paul Maria R. Parizel

5 October 2017 in Global Spine Journal
Verified
Journal Article
Open access
JDJulius Dengler
Julius Dengler
BSBengt Sturesson
Bengt Sturesson
DKDjaya Kools
Djaya Kools
DPDomenico Prestamburgo
Domenico Prestamburgo
DCDaniel Cher
Daniel Cher
PVPeter Vajkoczy
Peter Vajkoczy
Secondary analysis of data from a randomized controlled trial. To identify risk factors for continued opioid use after conservative management (CM) or minimally invasive surgical management (MISM) of low back pain (LBP) originating from the sacroiliac joint. Patients were randomized either to CM (n = 49) or MISM (n = 52). We documented opioid use, pain intensity (visual analogue scale [VAS]), Oswestry Disability Index (ODI), and the Zung depression score (Zung Self-Rating Depression Scale) at baseline and at months 3 and 6 after treatment initiation. Compared with opioid nonusers, opioid users at baseline had higher mean levels of disability (ODI 61.5, standard deviation [SD] 13.3 vs ODI 51.5, SD 12.8; P < .01) and higher depression scores (Zung 48.5, SD 8.5, vs Zung 42.2, SD 7.2; P < .01). At 6 months, opioid users had higher 6-month pain levels (VAS 60.4, SD 24.0, vs VAS 42.4, SD 28.2; P < .01), higher disability scores (ODI 50.5, SD 16.2, vs ODI 32.7, SD 19.3; P < .01) and higher depression scores (Zung 47.6, SD 8.0, vs Zung 38.8, SD 8.9; P < .01). Risk factors for continued opioid use at 6 months were patient age (odds ratio [OR] for age = 0.91; P = .02) and an increase in LBP (OR 1.08; P = .02) in the CM group and a lack of improvement in depression scores (OR 1.12; P = .03) in the MISM group. In our patient cohort, the risk of continued opioid use in the treatment of LBP increased not only with pain intensity but also with levels of depression during the course of treatment.